Oocyte-specific Wee1-like protein kinase 2 is dispensable for fertility in mice

Kaori Nozawa1,2, Zian Liao1,2, Yuhkoh Satouh3,4

  • 1Center for Drug Discovery, Baylor College of Medicine, Houston, TX, United States of America.

Plos One
|August 1, 2023
PubMed

Insights

Wee1-like protein kinase 2 (WEE2) loss-of-function in mice did not significantly impact fertility, suggesting alternative strategies for non-hormonal contraception development. Further research into gain-of-function or protein interactions is recommended.

Area of Science:

  • Reproductive biology
  • Molecular genetics
  • Biochemistry

Background:

  • Wee1-like protein kinase 2 (WEE2) is an oocyte-specific kinase crucial for meiotic arrest in human oocytes.
  • WEE2 has been proposed as a target for non-hormonal female contraception.
  • Pre-clinical models for WEE2 loss-of-function were previously unreported.

Purpose of the Study:

  • To develop and characterize CRISPR/Cas9-generated knockout mouse models to investigate the role of WEE2 in female fertility.
  • To assess the impact of WEE2 loss-of-function on oocyte meiotic arrest and overall reproductive success in mice.

Main Methods:

  • Generation of two distinct Wee2 knockout mouse models utilizing CRISPR/Cas9 gene editing.
  • Characterization of reproductive phenotypes, including litter size, litter production, and pup counts.
  • Analysis of key reproductive parameters such as ovarian weight, oocyte maturation, and meiotic arrest.

Main Results:

  • A frameshift mutation in exon 2 of Wee2 had no discernible effect on litter size, litter production, or oocyte meiotic arrest.
  • A large deletion model of Wee2 knockout showed a minor reduction in pup numbers in homozygous females compared to heterozygotes.
  • No significant differences were observed in ovarian weight, oocyte ovulation, or in vitro maturation rates between knockout and wild-type mice.

Conclusions:

  • Loss-of-function of WEE2 in mice demonstrates minimal impact on overall female fecundity, likely due to biological redundancies.
  • WEE2 loss-of-function is unlikely to be a viable strategy for non-hormonal contraception.
  • Future contraceptive development targeting WEE2 should explore gain-of-function mechanisms or protein-protein interactions.